申请人:SRI International
公开号:US04456618A1
公开(公告)日:1984-06-26
Naphthenic and heterocyclic retinoic acid analogues such as (E)-6-[2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethenyl]-2-naphthaldehyde, methyl 6-[2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethenyl]-2-naphthoate, 6-[2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethenyl]-2-naphthoic acid, (E)-1-(5-carbethoxy-2-furanyl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1- yl)-1,3-butadiene, (E)-1-(5-carboxy-2-furanyl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl) -1,3-butadiene, (E)-1-(5-carbethoxythien-2-yl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1- yl)-1,3-butadiene, and (E)-1-(5-carboxythien-2-yl)-2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl) -1,3-butadiene. These retinoids are useful as chemopreventive agents for inhibiting tumor promotion in epithelial cells and for treating nonmalignant skin disorders.
环烷和杂环
维甲酸类似物,如(E)-6-[2-(2,6,6-三甲基-1-
环己烯-1-基)
乙烯基]-2-
萘醛,甲基6-[2-(2,6,6-三甲基-1-
环己烯-1-基)
乙烯基]-2-
萘酸甲酯,6-[2-(2,6,6-三甲基-1-
环己烯-1-基)
乙烯基]-
2-萘甲酸,(E)-1-(5-羧乙氧基-2-
呋喃基)-2-甲基-4-(2,6,6-三甲基-1-
环己烯-1-基)-
1,3-丁二烯,(E)-1-(5-羧基-2-
呋喃基)-2-甲基-4-(2,6,6-三甲基-1-
环己烯-1-基)-
1,3-丁二烯,(E)-1-(5-羧乙氧基
噻吩-2-基)-2-甲基-4-(2,6,6-三甲基-1-
环己烯-1-基)-
1,3-丁二烯,以及(E)-1-(5-羧基
噻吩-2-基)-2-甲基-4-(2,6,6-三甲基-1-
环己烯-1-基)-
1,3-丁二烯。这些视黄
醇类化合物可用作抑制上皮细胞中的肿瘤
促进剂和治疗非恶性皮肤疾病的
化学预防剂。